Back to Trials
NCT07033117NARecruitingAccepts Healthy Volunteers

RaDIANT Health Systems Intervention

Indiana University

Start Date

10/27/2025

Completion Date

7/31/2027

Summary

The overarching goal of the proposed study is to determine whether the addition of structural interventions at the health system level targeting upstream barriers in the transplant process will improve access to transplant evaluation start.

Eligibility Criteria

Age Range: 18 years to 80 years

Inclusion Criteria: * Five large transplant centers (Emory Transplant Center and Piedmont Transplant Center in Atlanta, GA; Medical University of SC; Duke University in Durham, NC; and Indiana University in Indianapolis, IN) \~800 referring dialysis center referring to these transplant centers Exclusion Criteria: * Individuals referred, initiating evaluation, and waitlisted at non-participating start centers

Interventions

OTHER

Performance Feedback Reports on Referral and Evaluation Closures

OTHER

Dialysis Facility Awareness Campaign

OTHER

Patient Contact via Preferred Method

OTHER

Phone Call to Dialysis Facility During the Patient's Dialysis Session

OTHER

Phone Call to Provider

OTHER

Transplant Referral Communication Platforms or Email to Communicate Patient Status and No-Show

OTHER

Audit and Tracking of Patient Contact Attempts Prior to Referral Closure

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

End Stage Renal Disease (ESRD)Kidney Disease

Locations

Piedmont Transplant Institute

Atlanta, Georgia 30309

United States

Emory Transplant Center

Atlanta, Georgia 30322

United States

IU Health Transplant - Indianapolis

Indianapolis, Indiana 46202

United States

Duke Transplant Center

Durham, North Carolina 27710

United States

MUSC Mid-Carolinas Transplant Center

Lancaster, South Carolina 29720

United States